Navigation Links
Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device
Date:1/8/2014

NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Ensil's team of researchers and engineers have developed a medical device with patented technology that will help patients who suffer from mobility issues caused by spinal cord injuries, strokes or muscle disorders.

This product is called Vastusys (www.vastusys.com), and it works by replicating normal communication between the brain and the limbs via a proprietary, patented technology developed by Ensil. The product utilizes Ensil's innovative bluetooth protocol technology and multiple sensors to enable muscle movement and improve mobility.

"This is truly a ground-breaking achievement that will improve the lives of so many people," said Mr. Farsad Kiani, CEO of Ensil Canada. "I am excited to extend an open invitation to publicly traded companies to either acquire this technology or partner with Ensil to market and distribute this medical device to people around the world."

Ensil is currently inviting publicly traded companies to express interest in either acquiring the new technology or partnering with Ensil on the marketing and/or distribution of the Vastusys medical device.

Ensil Canada is a member of the Ensil group of companies (www.ensil.com), and it focuses on enhancing mission-critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's Research and Development division's mission is to develop new technologies or improve existing technologies, leveraging its in-house aerospace, defence and medical technology expertise, research and resources.

For nearly 30 years, a fundamental belief in "Innovation Beyond Imagination" has been part of Ensil's corporate culture. Since its inception, the company has built its brand in the North American Aerospace and Defence industries as a boutique engineering and R&D technology leader that is striving to improve the quality of life of people globally via innovative ideas and technologies.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
3. Canada-based Radimetrics Announces Expansion to Scotland
4. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
5. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
6. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
7. VirtualScopics Receives Issuance of Influential Patent in Canada
8. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
9. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
10. Sensus Healthcare Announces Health Canada Approval
11. New Treatment For Obstructive Sleep Apnea Now Available In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)...  Cardinal Health (NYSE: CAH ) today ... per share (EPS) guidance and providing a preliminary view ... with this morning,s announcement of the planned acquisition of ... businesses. Cardinal Health now believes that fiscal ... the bottom of its previous guidance range of $5.35 ...
(Date:4/18/2017)... , April 18, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a CAGR ... Global Arthroscopy Devices Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017 /PRNewswire/ ... results of collaboration started in 2016, in which ... "Artificial Brain SOINN". The companies achieved initial results ... ultrasound solution by Artificial Brain SOINN. The results ... Tokyo Big Sight, April 19-21, at booths 4505 ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and ... Foundation will present its annual Global Symposium at the Fontainebleau Hotel located in ...
(Date:4/24/2017)... ... April 24, 2017 , ... Insect Shield Repellent ... International relief organizations across the globe to provide effective protection against insects and ... wear collections via insectshield.com . In the wake of the Zika health ...
(Date:4/24/2017)... ... April 24, 2017 , ... A 2-in-1 bottleless ... same place. From 101 Water Texas, here are the ways in which this ... a continuous supply of pure, fresh, oxygenated water, with both cold and hot ...
(Date:4/23/2017)... , ... April 23, 2017 , ... ... managed services announced the achievement of Cisco Select certification and SMB specialization. ... United States. , In earning the Select Certification, Altura fulfilled the ...
Breaking Medicine News(10 mins):